Related Experiment Video
Updated: May 5, 2026
06:06
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
26.5K
Drug spotlight program: antacids and anticholinergic drugs.
Annals of Internal Medicine
|April 1, 1975
Summary
Controlled trials show antacids and anticholinergic drugs have limited scientific certainty. Individualized patient use is key, balancing effectiveness against potential side effects and colonic function impacts.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Antacids and anticholinergic drugs are commonly used for gastric acid reduction.
- Evidence for their effectiveness is often limited by methodological flaws in clinical trials.
Purpose of the Study:
- To evaluate the scientific certainty and clinical utility of antacids and anticholinergic drugs.
- To discuss the optimal use of these agents based on available evidence.
Main Methods:
- Review of controlled clinical trials assessing antacids and anticholinergic drugs.
- Analysis of drug effectiveness, side effects, and interactions.
Main Results:
- Few trials are free of significant criticism, limiting definitive conclusions on drug effectiveness.
- Anticholinergic drugs often produce side effects, making dose adjustment crucial.
- Newer antacids may offer improved neutralization but can impact colonic function.
Conclusions:
- The use of antacids and anticholinergic drugs lacks complete scientific certainty.
- Individualized patient treatment is essential, considering efficacy, side effects, and potential interactions.
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
01:24Cholinergic Antagonists: Pharmacokinetics
1.1K
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
1.1K
01:26Cholinergic Antagonists: Therapeutic Uses
1.7K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.7K
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
1.3K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.3K
01:31Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
1.1K
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
1.1K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
2.0K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
2.0K